Because oncology clinical trials are longer and more complex than those in any other therapeutic areas, they require a specialized team that understands and can readily execute the scientific and regulatory issues that are most relevant to the program.
Our oncology teams are built to work quickly, tactically and honestly with Sponsor and sites in a partnership philosophy. Focused oncology teams allow effective trial planning and execution from protocol development to database lock. Clinlogix works proactively to identify potential issues of concern, and provides solutions for the most efficient and successful trial.
With experience in trials from early through late-phase development (phase I – IV), including classic multicytotoxic agent and targeted and/or biologic therapy trials, the oncologic experts at Clinlogix deliver rapid and accurate results in trials of varied scope—from small, focused trials to large global studies.
Our team has successfully worked on oncology projects both commercially and with investigator-initiated trials (IIT) in the following indications:
• Breast cancer
• Bladder cancer
• Colon/rectal cancer
• Lung cancer
• Pancreatic cancer
• Prostate cancer
• Ovarian cancer